Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Almarza

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 31, 2007
Characteristics of lentiviral vectors harboring the proximal promoter of the vav proto-oncogene: a weak and efficient promoter for gene therapyElena Almarza, Paula Río, Nestor W Meza, et al.
Stem Cells (Dayton, Ohio)|June 7, 2014
Brief report: reduced expression of CD18 leads to the in vivo expansion of hematopoietic stem cells in mouse bone marrowDiego Leon-Rico, Montserrat Aldea, Rebeca Sanchez, et al.
Molecular Therapy. Methods & Clinical Development|February 12, 2021
Gene therapy for infantile malignant osteopetrosis: review of pre-clinical research and proof-of-concept for phenotypic reversalIlana Moscatelli, Elena Almarza, Axel Schambach, et al.
Stem Cell Research & Therapy|April 30, 2020
The downregulated membrane expression of CD18 in CD34<sup>+</sup> cells defines a primitive population of human hematopoietic stem cellsCristina Mesa-Núñez, Diego Leon-Rico, Montserrat Aldea, et al.
Human Gene Therapy|December 17, 2009
Development of lentiviral vectors with optimized transcriptional activity for the gene therapy of patients with Fanconi anemiaAfrica González-Murillo, M Luz Lozano, Lara Alvarez, et al.
Human Gene Therapy|April 9, 2016
Lentiviral Vector-Mediated Correction of a Mouse Model of Leukocyte Adhesion Deficiency Type IDiego Leon-Rico, Montserrat Aldea, Raquel Sanchez-Baltasar, et al.
Bioconjugate Chemistry|December 16, 2014
Parallel multifunctionalization of nanoparticles: a one-step modular approach for in vivo imagingHugo Groult, Jesús Ruiz-Cabello, Juan Pellico, et al.
The EMBO Journal|September 2, 2006
PARP-2 deficiency affects the survival of CD4+CD8+ double-positive thymocytesJosé Yélamos, Yolanda Monreal, Luis Saenz, et al.
Molecular Therapy. Methods & Clinical Development|September 12, 2022
Preclinical safety and efficacy of lentiviral-mediated gene therapy for leukocyte adhesion deficiency type ICristina Mesa-Núñez, Carlos Damián, María Fernández-García, et al.
Scientific Reports|October 18, 2017
In vivo imaging of lung inflammation with neutrophil-specific <sup>68</sup>Ga nano-radiotracerJuan Pellico, Ana V Lechuga-Vieco, Elena Almarza, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 31, 2007
Characteristics of lentiviral vectors harboring the proximal promoter of the vav proto-oncogene: a weak and efficient promoter for gene therapyElena Almarza, Paula Río, Nestor W Meza, et al.
Stem Cells (Dayton, Ohio)|June 7, 2014
Brief report: reduced expression of CD18 leads to the in vivo expansion of hematopoietic stem cells in mouse bone marrowDiego Leon-Rico, Montserrat Aldea, Rebeca Sanchez, et al.
Molecular Therapy. Methods & Clinical Development|February 12, 2021
Gene therapy for infantile malignant osteopetrosis: review of pre-clinical research and proof-of-concept for phenotypic reversalIlana Moscatelli, Elena Almarza, Axel Schambach, et al.
Stem Cell Research & Therapy|April 30, 2020
The downregulated membrane expression of CD18 in CD34<sup>+</sup> cells defines a primitive population of human hematopoietic stem cellsCristina Mesa-Núñez, Diego Leon-Rico, Montserrat Aldea, et al.
Human Gene Therapy|December 17, 2009
Development of lentiviral vectors with optimized transcriptional activity for the gene therapy of patients with Fanconi anemiaAfrica González-Murillo, M Luz Lozano, Lara Alvarez, et al.
Human Gene Therapy|April 9, 2016
Lentiviral Vector-Mediated Correction of a Mouse Model of Leukocyte Adhesion Deficiency Type IDiego Leon-Rico, Montserrat Aldea, Raquel Sanchez-Baltasar, et al.
Bioconjugate Chemistry|December 16, 2014
Parallel multifunctionalization of nanoparticles: a one-step modular approach for in vivo imagingHugo Groult, Jesús Ruiz-Cabello, Juan Pellico, et al.
The EMBO Journal|September 2, 2006
PARP-2 deficiency affects the survival of CD4+CD8+ double-positive thymocytesJosé Yélamos, Yolanda Monreal, Luis Saenz, et al.
Molecular Therapy. Methods & Clinical Development|September 12, 2022
Preclinical safety and efficacy of lentiviral-mediated gene therapy for leukocyte adhesion deficiency type ICristina Mesa-Núñez, Carlos Damián, María Fernández-García, et al.
Scientific Reports|October 18, 2017
In vivo imaging of lung inflammation with neutrophil-specific <sup>68</sup>Ga nano-radiotracerJuan Pellico, Ana V Lechuga-Vieco, Elena Almarza, et al.
Pageof 3